Avalon GloboCare Corp. (NASDAQ:ALBT – Get Rating) shares fell 4.3% during mid-day trading on Thursday . The stock traded as low as $1.73 and last traded at $1.76. 9,828 shares were traded during trading, a decline of 94% from the average session volume of 152,926 shares. The stock had previously closed at $1.84.
Avalon GloboCare Trading Down 4.3 %
The company has a debt-to-equity ratio of 2.11, a current ratio of 0.27 and a quick ratio of 0.66. The firm has a fifty day simple moving average of $1.93.
Avalon GloboCare (NASDAQ:ALBT – Get Rating) last announced its quarterly earnings data on Monday, May 22nd. The company reported ($0.28) earnings per share for the quarter. The business had revenue of $0.30 million for the quarter. Avalon GloboCare had a negative return on equity of 662.37% and a negative net margin of 1,053.75%.
Institutional Investors Weigh In On Avalon GloboCare
About Avalon GloboCare
Avalon GloboCare Corp. is a clinical-stage biotechnology company, which engages in the development of immune effector cell therapy and laboratory services. It operates through the Real Property Operating and Medical Related Consulting Services segments. The Real Property Operating segment includes property management fees, property insurance, real estate taxes, depreciation, repairs and maintenance fees, utilities and other expenses related to rental properties.
- Get a free copy of the StockNews.com research report on Avalon GloboCare (ALBT)
- Ralph Lauren’s Styled Dividend Is Still In Season
- Dollar Tree Falls As Theft Cuts Into Bottom Line
- Best Buy’s Comeback Is Still At Play, Earnings Call For Patience
- e.l.f. Beauty Has Giant Quarter, Shares Hit New High
- If You Can Only Pick One Stock For The Rest Of 2023, Pick Nvidia
Receive News & Ratings for Avalon GloboCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Avalon GloboCare and related companies with MarketBeat.com's FREE daily email newsletter.